PEDIATRICS Vol. 102 No. 5 November 1998, p. e61

* Department of Pediatrics
Division of Epidemiology, School of Public Health
University of Minnesota Medical School
Minneapolis, MN 55405
| |
ABSTRACT |
|---|
|
|
|---|
It is apparent from the results of the 1995 and 1998 surveys reported by Kimm et al in this issue of Pediatrics that pediatricians are interested in blood pressure and lipids but uncertain about the management of these coronary heart disease (CHD) risk factors. Data from longitudinal epidemiologic studies initiated in pediatric cohorts support the important role for pediatricians in the detection of children at risk for CHD, and detection should be followed by effective intervention/treatment programs. However, the latter may be difficult in most office practices, because of the intensive effort by specialized personnel required to successfully reduce CHD risk.
Key words: coronary heart disease risk factors, hypertension, hyperlipidemia.
Within the past two decades pediatricians have been
encouraged to address coronary heart disease (CHD) risk factors. In
this issue of Pediatrics, Kimm et al1 compare
results from physician surveys in 1988 and 1995 regarding attitudes and
management of hypertension and hyperlipidemia in children. Surveys of
this type are often difficult because of problems in selection of
representative samples and the attainment of adequate response rates.
These and other problems specific to this survey (eligibility for the
interview based on only a minimum of five pediatric visits/week;
physicians not required to have seen any children with either
hypertension or hyperlipidemia; different questionnaires used among the
physicians) raise some questions about the applicability of the
authors' conclusions to the general pediatric community. Nevertheless,
it is apparent that the outcomes from 1995 and 1988 confirm the
findings of previous surveys of pediatricians.2,3 First,
although there continues to be an interest in blood pressure and lipids among US physicians treating children, there is considerable
uncertainty about management of CHD risk factors. Second, there is a
reluctance to refer at-risk children to specialists despite a sense
that intervention is not as successful as it should be. Thus, despite publication within the past decade of national guidelines for diagnosis, evaluation, and treatment of hyperlipidemia and
hypertension,4,5 there continue to be important issues
about CHD prevention in children.
CHD is a major cause of premature morbidity and mortality in adults.
Prevention has focused on the well-recognized risk factors of
hypertension, hyperlipidemia, and obesity. A natural extension of this
campaign has been the targeting of CHD risk factors in children, with
the rationale that the prevalence of CHD in adults can be reduced by
early identification of at-risk subjects and introduction of effective
intervention strategies. Data from longitudinal epidemiologic studies
initiated in pediatric cohorts in the 1970s6-8 support
this approach. A significant tracking effect for blood pressure and
lipids is present from childhood through adolescence and into
adulthood.9,10 Moreover, the association of these risk
factors with hyperinsulinemia, known as the insulin resistance
syndrome,11-13 is also present during childhood. Levels of
fasting insulin in children are directly associated with
lipid14 and blood pressure levels,15 and in
adolescents with lipid levels, blood pressure, weight, and parental
levels of fasting insulin.16 The early adverse effect of
these risk factors has been confirmed by autopsy studies of children in
whom the degree of aortic and coronary artery atherosclerosis found at
autopsy is significantly associated with levels of blood pressure and
lipids obtained before death.17
The Kimm survey did not address obesity, an essential CHD risk factor
linked to hypertension, hyperlipidemia, and atherosclerotic lesions.11-13,17 Not only do a majority of obese children
become obese adults18 but overweight during adolescence is
associated with an increased risk of adult CHD.19,20 As
recently noted, the prevalence of obesity in the childhood population
is increasing steadily.21
Pediatricians should play an important role in the detection of
children at risk for CHD. Almost all pediatricians routinely measure
blood pressure. Although very few cases of hypertension will be missed,
the prevalence of hypertension in children is low; only 1% or less of
junior high school-aged children will have elevated blood
pressure,22 and even fewer cases will be found in younger
children.23 The recommendations for cholesterol screening
are clear,5 and following the guidelines should identify
most children with elevated levels.24
Detection should be followed by effective intervention/treatment
programs. This may not be feasible in the average office practice.
Dietary modifications for sodium and potassium25 and
lipids26 have been shown in clinical trials to reduce levels of risk. However, these results were accomplished with a
dedicated group of interventionists and physicians committed to patient
and family reinforcement. Few physicians have the systems in place to
support the level of activity required for effective risk factor
intervention. Thus, it is not surprising that the physicians
interviewed in the Kimm study felt a lack of success with their
management. In most instances, referral to an experienced specialist is
of benefit to the patient, family, and referring physician.
The primary mission of pediatrics has always been prevention of disease
and ensuring normal growth and development. Cardiovascular health
should be an integral component of this mission. This can best be
achieved by active participation of pediatricians in the detection of
at-risk individuals followed by effective intervention programs.
![]()
ARTICLE
Top
Abstract
Article
References
| |
FOOTNOTES |
|---|
Received for publication Sep 10, 1998; accepted Sep 14, 1998.
Reprint requests to (A.R.S.) University of Minnesota, Department of Pediatrics, Box 491 FUMC, 420 Delaware St SE, Minneapolis, MN 55455.
| |
ABBREVIATIONS |
|---|
CHD, coronary heart disease.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Nussinovitch, K. Elishkevitz, T. Rosenthal, and M. Nussinovitch Screening for Hypertension in High School Clinical Pediatrics, October 1, 2005; 44(8): 711 - 714. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||